Economic and Quality-of-Life Aspects of Treating Small Cell Lung Cancer
- 1 June 1993
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 3 (6) , 446-453
- https://doi.org/10.2165/00019053-199303060-00004
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Assessing the quality of life of patients in cancer clinical trials: Common problems and common sense solutionsEuropean Journal Of Cancer, 1992
- Quality-of-Life Assessment in Small Cell Lung CancerPharmacoEconomics, 1992
- Proposal for Assuring Technology Competency and Leadership in MedicineJNCI Journal of the National Cancer Institute, 1992
- Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Quality of Life During Chemotherapy for Small Cell Lung Cancer :I. An evaluation with generic health measuresActa Oncologica, 1991
- Quality adjusted survival analysisStatistics in Medicine, 1990
- Small cell lung cancer: single agents revisitedRespiratory Medicine, 1989
- Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer: Report to the medical research council by its lung cancer working partyRespiratory Medicine, 1989
- Nonmedical costs to patients and their families associated with outpatient chemotherapyCancer, 1984
- THE EVALUATION OF THE RESULTS OF CANCER THERAPY TREATMENT UTILITY1Anz Journal of Surgery, 1981